[
    "{\"step_by_step_thinking\": \"Dupilumab is a monoclonal antibody that is designed to inhibit overactive signaling of two key proteins, IL-4 and IL-13, which are believed to drive the underlying inflammation in atopic dermatitis. The FDA approval of a drug means that data on the drug's effects have been reviewed by CDER, and the drug is determined to provide benefits that outweigh its known and potential risks for the intended population. I know that Dupilumab, marketed as Dupixent, has been approved by the FDA for the treatment of atopic dermatitis.\", \"answer_choice\": \"A\"}"
]